1. Department of Economics and Social Affairs;Contraceptive Use by Method,2019
2. Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?;Polis;Contraception,2018
3. PATH. How to Introduce and Scale Up Subcutaneous DMPA (Sayana Press): practical Guidance from PATH Based on Lessons Learned During Pilot Introduction. 2018.
4. DEPO-SUBQ PROVERA 104 (medroxyprogesterone acetate) injectable suspension, for subcutaneous use;Prescribing Information,2020
5. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive;Pantoja;Contraception,2010